project id: TCGA-CESC; case submitter id: TCGA-C5-A7X3; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 7.1; age at index: 70; days to birth: -25665; days to death: 284; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1927; year of death: 1997; age at diagnosis: 25665; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 1997; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 5915; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-C5-A7X3-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 5.0; percent necrosis: 1.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 39.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;